Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	11,654	11,155	12,302	9,348	9,415	10,242
Market Cap Growth	2.36%	-9.32%	31.60%	-0.71%	-8.08%	49.25%
Enterprise Value	11,527	11,097	11,669	8,972	9,322	10,305
Last Close Price	14.21	13.13	14.53	11.21	10.90	11.97
PE Ratio	18.51	16.86	18.41	17.03	30.32	43.47
PS Ratio	3.03	2.93	3.67	3.12	3.33	3.95
PB Ratio	2.79	2.83	3.65	3.32	3.75	4.33
P/TBV Ratio	4.06	4.24	4.28	3.92	4.50	5.64
P/FCF Ratio	28.85	50.37	35.31	16.14	53.13	28.86
P/OCF Ratio	16.59	20.53	22.56	13.04	25.42	20.99
EV/Sales Ratio	3.00	2.91	3.48	3.00	3.30	3.97
EV/EBITDA Ratio	12.22	10.67	12.26	11.16	14.82	16.50
EV/EBIT Ratio	15.59	12.98	14.82	13.79	19.70	22.91
EV/FCF Ratio	28.53	50.10	33.49	15.50	52.61	29.04
Debt / Equity Ratio	0.18	0.14	0.07	0.06	0.18	0.18
Debt / EBITDA Ratio	0.79	0.52	0.25	0.20	0.71	0.66
Debt / FCF Ratio	1.85	2.47	0.69	0.28	2.52	1.17
Asset Turnover	0.66	0.74	0.79	0.80	0.77	0.76
Inventory Turnover	2.06	2.01	2.06	2.14	2.09	2.15
Quick Ratio	1.18	1.16	1.72	1.58	1.24	1.07
Current Ratio	1.88	1.92	2.58	2.38	1.93	1.78
Return on Equity (ROE)	16.10%	18.53%	21.77%	21.38%	12.96%	10.51%
Return on Assets (ROA)	7.96%	10.37%	11.56%	10.86%	8.04%	8.27%
Return on Invested Capital (ROIC)	14.38%	19.98%	25.30%	21.99%	15.03%	13.42%
Return on Capital Employed (ROCE)	16.40%	20.10%	22.50%	22.60%	18.10%	18.10%
Earnings Yield	5.40%	5.93%	5.43%	5.87%	3.30%	2.30%
FCF Yield	3.47%	1.98%	2.83%	6.19%	1.88%	3.46%
Dividend Yield	0.50%	0.71%	0.66%	0.87%	0.73%	0.57%
Payout Ratio	9.46%	11.78%	11.94%	11.05%	17.59%	24.06%
Buyback Yield / Dilution	0.15%	-0.08%	-0.19%	-0.03%	-0.01%	-0.14%
Total Shareholder Return	0.66%	0.64%	0.47%	0.84%	0.71%	0.43%

Updated Jan 21, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q